C K Goldman - JoVE Visualize

Showing results (31-40 of 49) with videos related to

Pageof 5

Sort By:

International Journal of Cancer|June 25, 1998

Adenovirus-mediated p16 gene transfer prevents drug-induced cell death through G1 arrest in human glioma cellsS Hama, Y Heike, I Naruse, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998

Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovaryC Rancourt, M W Robertson, M Wang, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibodyR W Kozak, D P Fitzgerald, R W Atcher, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987

Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptideJ Szöllösi, S Damjanovich, C K Goldman, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994

A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cellsJ D Burton, R N Bamford, C Peters, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994

The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cellsR N Bamford, A J Grant, J D Burton, et al.

Blood|November 1, 1988

Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2T A Waldmann, C K Goldman, K F Bongiovanni, et al.

Cancer Research|April 15, 1997

Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptorC K Goldman, B E Rogers, J T Douglas, et al.

Blood|September 15, 1993

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemiaT A Waldmann, J D White, C K Goldman, et al.

Transplantation|December 1, 1992

Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factorG L Parenteau, F M Dirbas, K Garmestani, et al.

Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:

Pageof 5

International Journal of Cancer|June 25, 1998

Adenovirus-mediated p16 gene transfer prevents drug-induced cell death through G1 arrest in human glioma cellsS Hama, Y Heike, I Naruse, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998

Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovaryC Rancourt, M W Robertson, M Wang, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibodyR W Kozak, D P Fitzgerald, R W Atcher, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987

Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptideJ Szöllösi, S Damjanovich, C K Goldman, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994

A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cellsJ D Burton, R N Bamford, C Peters, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 24, 1994

The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cellsR N Bamford, A J Grant, J D Burton, et al.

Blood|November 1, 1988

Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2T A Waldmann, C K Goldman, K F Bongiovanni, et al.

Cancer Research|April 15, 1997

Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptorC K Goldman, B E Rogers, J T Douglas, et al.

Blood|September 15, 1993

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemiaT A Waldmann, J D White, C K Goldman, et al.

Transplantation|December 1, 1992

Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factorG L Parenteau, F M Dirbas, K Garmestani, et al.

Pageof 5